Cash Cash Equivalents - Bayer AG (XETRA:BAYN) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 27.865 EUR -0.94%

Updated:

Bayer AG
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Bayer AG
Cash & Cash Equivalents Peer Comparison

ATAI

MRK

93M1

DMP

PSG

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Bayer AG XETRA:BAYN	Cash & Cash Equivalents €5.9B	CAGR 3-Years 12%	CAGR 5-Years 8%	CAGR 10-Years 14%
	ATAI Life Sciences NV NASDAQ:ATAI	Cash & Cash Equivalents $45m	CAGR 3-Years -23%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Merck KGaA XETRA:MRK	Cash & Cash Equivalents €2B	CAGR 3-Years 14%	CAGR 5-Years -2%	CAGR 10-Years 7%
	MPH Health Care AG XETRA:93M1	Cash & Cash Equivalents €1.8m	CAGR 3-Years 1%	CAGR 5-Years 8%	CAGR 10-Years N/A
	Dermapharm Holding SE XETRA:DMP	Cash & Cash Equivalents €158.7m	CAGR 3-Years 10%	CAGR 5-Years 14%	CAGR 10-Years N/A
	PharmaSGP Holding SE XETRA:PSG	Cash & Cash Equivalents €32.6m	CAGR 3-Years -28%	CAGR 5-Years -15%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Bayer AG's Cash & Cash Equivalents amounts to 5.9B EUR.

Over the last year, the Cash & Cash Equivalents growth was 14%. The average annual Cash & Cash Equivalents growth rates for Bayer AG have been 12% over the past three years , 8% over the past five years , and 14% over the past ten years .

Join more than 133,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.